DY6
0.135
92.9%
EEL
0.001
-50%
LKY
0.042
82.6%
HCF
0.02
-44.4%
DTR
0.036
63.6%
DTM
0.003
-40%
DES
0.165
57.1%
MTB
0.003
-40%
HRE
0.029
52.6%
DYM
0.215
-34.8%
TMK
0.003
50%
JAV
0.002
-33.3%
WCN
0.034
47.8%
MIO
0.018
-33.3%
AZL
0.01
42.9%
VFX
0.002
-33.3%
YAR
0.007
40%
ANX
0.007
-30%
VRX
0.057
39%
IFG
0.005
-28.6%
WJL
0.895
37.7%
HLS
1.155
-26.2%
CMD
0.022
37.5%
XPN
0.015
-25%
VRL
0.022
37.5%
C29
0.035
-23.9%
BCB
0.475
33.8%
BB1
0.32
-21%
CRB
0.004
33.3%
1AD
0.004
-20%
GGE
0.004
33.3%
AVE
0.004
-20%
OSL
0.004
33.3%
PUR
0.037
-19.6%
PPY
0.012
33.3%
OPL
0.021
-19.2%
THB
0.012
33.3%
NWM
0.013
-18.8%
VEN
0.004
33.3%
EV1
0.009
-18.2%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

The Calmer Co. International (ASX:CCO) generates over $150,000 in sales from its kava-based health drinks now available at Coles

ASX:CCO Share Price

The Calmer Co. International (ASX:CCO) has revealed April ecommerce sales have continued to grow strongly, having now surpassed $11,000 per day.

  • Coles scan sales over the initial launch period exceed $150,000 and were running at over $30,000 per week and greater than 4,600 units per week, in week 8 after launch
  • ecommerce sales continue to grow month-on-month and now exceed $11,000 per day

Anthony Noble, CEO of The Calmer Co. International, says: “Excellence in ecommerce is our primary growth pillar. We have continued to grow month-on-month in these channels, with both Shopify and Amazon contributing.”

“The initial sales results for the new range of three products in Coles are extremely promising and this is now backed up by scan data showing a rapid acceleration in both value of retail sales and units sold across the discount cycle in Coles.”

Write to us
  • © 2025 Copyright
  • The Stock Network
  • All rights reserved